Indoleamine 2,3-dioxygenase

There are 8 papers on indoleamine 2,3-dioxygenase in aging research: 3 observational studies in people, 1 in animals, 4 in cells.

Biomarker

8 papers study it37 more mention it4 findings

1 new paper in 30 daysSee all 45 papers on indoleamine 2,3-dioxygenase

“IDO activity independently predicted MetS. In ROC curve analysis, TG/HDL-C demonstrated high (AUC = 0.886) and IDO activity moderate (AUC = 0.646) performance in predicting Mtes.”
Dysregulated indoleamine 2,3-dioxygenase contributes to metabolic syndromeJournal of diabetes and metabolic disorders2026doi:10.1007/s40200-026-01889-5
  • Humans3
  • Animals1
  • Cells4

Interventions

2

Quercetin

no changein human cells1

1 study
  1. Quercetin showed no clear effect on indoleamine 2,3-dioxygenase in human cells.

    “Quercetin treatment did not, however, negatively affect adipogenesis, chondrogenesis, or indoleamine 2,3 dioxygenase secretions.”

    Cells10 μM

    Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells

    Cellular and molecular bioengineering

More on Quercetin

Dasatinib

no changein cells1

1 study
  1. Dasatinib showed no clear effect on indoleamine 2,3-dioxygenase in cells (senescent and non-senescent cultures).

    “Indoleamine Dioxygenase activity showed insignificant differences in cells exposed to dasatinib versus control groups”

    Cellssenescent and non-senescent culturescultured-cells

    Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells

    Cellular and molecular bioengineering

More on Dasatinib

Associations

2

Uric acid

upin humans1

1 study
  1. Uric acid predicts indoleamine 2,3-dioxygenase in humans (r = 0.315, P < 0.001).

    “Multiple regression analyses showed that uric acid (r = 0.315; P < 0.001) was an independent predictor of IDO activity in all subjects.”

    Humansfemalesn = 140

    Dysregulated indoleamine 2,3-dioxygenase contributes to metabolic syndrome

    Journal of diabetes and metabolic disorders

More on Uric acid

Metabolic syndrome

upin humans1

1 study
  1. Indoleamine 2,3-dioxygenase predicts metabolic syndrome in humans (AUC = 0.646).

    “IDO activity independently predicted MetS. In ROC curve analysis, TG/HDL-C demonstrated high (AUC = 0.886) and IDO activity moderate (AUC = 0.646) performance in predicting Mtes.”

    Humansfemalesn = 140

    Dysregulated indoleamine 2,3-dioxygenase contributes to metabolic syndrome

    Journal of diabetes and metabolic disorders

More on Metabolic syndrome

Latest

Dec 2025: 2Jan 2026: 2Feb 2026: 2Mar 2026: 0Apr 2026: 1May 2026: 1Jun 2026: 1Jul 2026: 1Aug 2026: 2Sep 2026: 0Oct 2026: 1Nov 2026: 114 papers in 12 months

See all 45 papers on indoleamine 2,3-dioxygenase